Literature DB >> 23887763

Marchiafava-Bignami disease: a rare entity with a poor outcome.

Paulo Eduardo Mestrinelli Carrilho1, Marcius Benigno Marques Dos Santos, Larisa Piasecki, Amaury Cezar Jorge.   

Abstract

Marchiafava-Bignami disease is a rare affliction characterized by primary degeneration of the corpus callosum associated with chronic consumption of ethanol. The disease may occasionally occur in patients who are not alcoholics but are chronically malnourished. A complex deficiency of group B vitamins is the main etiopathogenic hypothesis, and many patients improve after the administration of these compounds. However, a good response is not always observed. The definitive diagnosis of Marchiafava-Bignami disease can be problematic and is based on features of neuroimaging studies, especially magnetic resonance imaging. Its treatment is still controversial and shows variable results. Because nutritional factors are implicated, as in Wernicke's encephalopathy, some authors claim that replacement of B vitamins is beneficial. The present article is a case report of a severe acute form of Marchiafava-Bignami disease in an alcohol-dependent male patient who improved after the administration of parenteral B vitamins. As a consequence of his neurological and immunologic conditions, he developed multiple pulmonary infections and had a protracted course in the intensive care unit. He eventually died of sepsis associated with an uncommon fungus, Rhodotorula mucilaginosa. The present article reports the clinical and neuroimaging data from this patient and contains a review of Marchiafava-Bignami disease and Rhodotorula infections in the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887763      PMCID: PMC4031867          DOI: 10.1590/s0103-507x2013000100013

Source DB:  PubMed          Journal:  Rev Bras Ter Intensiva        ISSN: 0103-507X


  24 in total

1.  [Reversible demyelinisation of corpus callosum in the course of Marchiafava-Bignami disease].

Authors:  Jacek Staszewski; Katarzyna Macek; Adam Stepień
Journal:  Neurol Neurochir Pol       Date:  2006 Mar-Apr       Impact factor: 1.621

2.  Microbiological characteristics and susceptibility patterns of strains of Rhodotorula isolated from clinical samples.

Authors:  F Galán-Sánchez; P García-Martos; C Rodríguez-Ramos; P Marín-Casanova; J Mira-Gutiérrez
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

3.  [A case of Marchiafava-Bignami disease that responded to high-dose intravenous corticosteroid administration].

Authors:  Y Kikkawa; Y Takaya; N Niwa
Journal:  Rinsho Shinkeigaku       Date:  2000-11

4.  Susceptibility profile of 29 clinical isolates of Rhodotorula spp. and literature review.

Authors:  Alicia Gomez-Lopez; Emilia Mellado; Juan L Rodriguez-Tudela; Manuel Cuenca-Estrella
Journal:  J Antimicrob Chemother       Date:  2005-02-04       Impact factor: 5.790

Review 5.  Transient fungemia due to Rhodotorula rubra in a cancer patient: case report and review of the literature.

Authors:  G Samonis; M Anatoliotaki; H Apostolakou; S Maraki; D Mavroudis; V Georgoulias
Journal:  Infection       Date:  2001 May-Jun       Impact factor: 3.553

6.  Marchiafava-Bignami disease.

Authors:  S Raina; D M Mahesh; J Mahajan; S S Kaushal; D Gupta; D S Dhiman
Journal:  J Assoc Physicians India       Date:  2008-08

7.  Rhodotorula mucilaginosa as a cause of persistent femoral nonunion.

Authors:  R Goyal; S Das; A Arora; A Aggarwal
Journal:  J Postgrad Med       Date:  2008 Jan-Mar       Impact factor: 1.476

Review 8.  Rhodotorula infection. A systematic review of 128 cases from literature.

Authors:  Felipe F Tuon; Silvia F Costa
Journal:  Rev Iberoam Micol       Date:  2008-09-30       Impact factor: 1.044

9.  Transient encephalopathy in a postoperative non-alcoholic female with Marchiafava-Bignami disease.

Authors:  Lesli E Rusche-Skolarus; Brendan P Lucey; Katie D Vo; B Joy Snider
Journal:  Clin Neurol Neurosurg       Date:  2007-06-21       Impact factor: 1.876

10.  Femoral prosthesis infection by Rhodotorula mucilaginosa.

Authors:  Vincenzo Savini; Federica Sozio; Chiara Catavitello; Marzia Talia; Assunta Manna; Fabio Febbo; Andrea Balbinot; Giovanni Di Bonaventura; Raffaele Piccolomini; Giustino Parruti; Domenico D'Antonio
Journal:  J Clin Microbiol       Date:  2008-08-27       Impact factor: 5.948

View more
  8 in total

1.  [Radiological characteristics of a rare, alcohol-associated, neurological disease].

Authors:  A Arévalo Hernández; M Wittstock; M-A Weber; A Großmann
Journal:  Radiologie (Heidelb)       Date:  2022-05-25

2.  Marchiafava-Bignami disease with rare etiology: A case report.

Authors:  Yongjian Cui; Lei Zheng; Xiaoli Wang; Weiwen Zhang; Dongcai Yuan; Yan Wei
Journal:  Exp Ther Med       Date:  2015-02-05       Impact factor: 2.447

3.  Amantadine as a Potential Treatment for Marchiafava-Bignami Disease: Case Reports and a Possible Mechanism.

Authors:  Leenil Noel; Martin Myers; Tigran Kesayan
Journal:  Case Rep Neurol Med       Date:  2022-04-11

4.  Intermediate Syndrome and Marchiafava-Bignami Syndrome: Double Trouble in Weaning Off.

Authors:  Ruchita Kabra; Maharshi Patel; Pratik J Bhansali; Sunil Kumar; Sourya Acharya
Journal:  Cureus       Date:  2022-07-09

5.  Reaction Time and Visual Memory in Connection with Alcohol Use in Schizophrenia and Schizoaffective Disorder.

Authors:  Atiqul Haq Mazumder; Jennifer Barnett; Nina Lindberg; Minna Torniainen-Holm; Markku Lähteenvuo; Kaisla Lahdensuo; Martta Kerkelä; Jarmo Hietala; Erkki Tapio Isometsä; Olli Kampman; Tuula Kieseppä; Tuomas Jukuri; Katja Häkkinen; Erik Cederlöf; Willehard Haaki; Risto Kajanne; Asko Wegelius; Teemu Männynsalo; Jussi Niemi-Pynttäri; Kimmo Suokas; Jouko Lönnqvist; Solja Niemelä; Jari Tiihonen; Tiina Paunio; Aarno Palotie; Jaana Suvisaari; Juha Veijola
Journal:  Brain Sci       Date:  2021-05-23

Review 6.  Alcohol's Effects on the Brain: Neuroimaging Results in Humans and Animal Models.

Authors:  Natalie M Zahr; Adolf Pfefferbaum
Journal:  Alcohol Res       Date:  2017

7.  Clinical and radiological features of Marchiafava-Bignami disease.

Authors:  Xiaoyu Dong; Chaobo Bai; Jianfei Nao
Journal:  Medicine (Baltimore)       Date:  2018-02       Impact factor: 1.889

8.  Marchiafava-Bignami Disease Associated with Spinal Involvement.

Authors:  Jhon Perea; María Belén Luis; Luciana Grimanesa Lázaro; Sergio Scollo; Agustina Tamargo; José Crespo; Maira Avalle; Horacio Solarz; Nora Fernández Liguori; Ricardo Alonso
Journal:  Case Rep Neurol Med       Date:  2020-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.